Georgetown University LogoGeorgetown University Library LogoDigitalGeorgetown Home
    • Login
    View Item 
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Lombardi Comprehensive Cancer Center
    • Program of Tumor Biology
    • Graduate Theses and Dissertations - Tumor Biology
    • View Item
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Lombardi Comprehensive Cancer Center
    • Program of Tumor Biology
    • Graduate Theses and Dissertations - Tumor Biology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Addressing Thoracic Cancers: Biomarker and Pre-Clinical Drug Discovery in Non-Small Cell Lung Cancer and Thymic Carcinoma

    Restricted Access
    View/Open
    View/Open: Chen_georgetown_0076D_14852.pdf (2.7MB)

    Creator
    Chen, Vincent
    Advisor
    Giaccone, Giuseppe
    Byers, Stephen
    Abstract
    Thoracic cancer is a term that encompasses numerous malignancies within the thoracic cavity; the term includes malignancies such as lung cancers and thymic epithelial tumors. Lung cancers are the leading cause of cancer death in the United States and worldwide, resulting in the need for more effective therapeutics. Likewise, systemic treatments for thymic carcinoma, a type of thymic epithelial tumor, are not very effective. This dissertation will address the need for more effective therapeutics by investigating a potential mechanism of drug resistance in non-small cell lung carcinoma in the first chapter. In the second chapter, mesothelin will be investigated as a drug delivery target in thymic carcinoma.
     
    Adenocarcinoma, which is the most common subtype of non-small cell lung cancer (NSCLC), often harbors oncogenic driver mutations in the epidermal growth factor receptor (EGFR). Osimertinib (AZD9291), a third generation EGFR tyrosine kinase inhibitor (TKI), has replaced earlier generation EGFR TKIs for the first-line treatment of EGFR mutant lung cancer. However, like earlier generation EGFR TKIs, not all patients respond, indicating an unknown mechanism of intrinsic resistance for the non-responders. It has been demonstrated that CRIPTO expression is a potential mechanism of intrinsic resistance to first and second generation EGFR TKIs. Therefore, we wanted to determine if CRIPTO could also promote drug resistance against third generation EGFR TKIs like osimertinib. We found that CRIPTO is unable to elicit resistance against third generation EGFR TKI osimertinib, despite previous research indicating CRIPTO’s role in resistance against earlier generation EGFR TKIs; however, we also found that CRIPTO is a potentially useful biomarker in tracking cancer progression in NSCLC patients.
     
    Thymic epithelial tumors (TETs) are rare cancers with an incidence rate of 0.32 per 100,000 persons. Being a rare malignancy, the biology of these tumors is not well understood, and there are currently no FDA approved therapies. Of all TETs, thymic carcinoma is the most aggressive, with a 5-year survival rate of 30%, compared to 90% in thymomas. We investigated utilizing mesothelin (MSLN), a cell surface glycoprotein that is expressed in TETs but has limited expression elsewhere in the body, as a drug delivery target for thymic carcinoma. We found that anetumab ravtansine, an antibody drug conjugate, was able to bind and be internalized by MSLN expressing thymic carcinoma. We also found that anetumab ravtansine was effective at inhibiting mesothelin expressing thymic carcinoma in vitro and in vivo, despite our findings that MSLN increases drug resistance against cytotoxic therapies such as cisplatin.
     
    Description
    Ph.D.
    Permanent Link
    http://hdl.handle.net/10822/1062382
    Date Published
    2020
    Subject
    Molecular biology; Medicine; Pharmacology; Molecular biology; Medicine; Pharmacology;
    Type
    thesis
    Embargo Lift Date
    2023-08-12
    Publisher
    Georgetown University
    Extent
    96 leaves
    Collections
    • Graduate Theses and Dissertations - Tumor Biology
    Metadata
    Show full item record

    Related items

    Showing items related by title, author, creator and subject.

    • Thumbnail

      Patient Willingness to Undergo Chemotherapy and Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer 

      Hirose, Takashi; Yamaoka, Toshimitsu; Ohnishi, Tsukasa; Sugiyama, Tomohide; Kusumoto, Sojiro; Shirai, Takao; Okuda, Kentaro; Ohmori, Tohru; Adachi, Mitsuru (2009-05)
    Related Items in Google Scholar

    Georgetown University Seal
    ©2009 - 2022 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility
     

     

    Browse

    All of DigitalGeorgetownCommunities & CollectionsCreatorsTitlesBy Creation DateThis CollectionCreatorsTitlesBy Creation Date

    My Account

    Login

    Statistics

    View Usage Statistics

    Georgetown University Seal
    ©2009 - 2022 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility